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Breast cancerAbstract Objective: To evaluate the ability of Diffusion weighted MR imaging (DWI), as a non-
invasive sequence to differentiate between accepted post operative sequel and residual malignancy
in breast cancer patients following different surgical procedures.
Patients and methods: DWI in addition to the routine post contrast MRI was performed for follow
up of 170 post operative breasts (6–24 months). DWI acquired using b values: 0, 850, 1000 and
1500. Analysis considered signal intensity (SI) at b 1000 and the ADC map and the mean ADC val-
ues.
Results: Post operative changes were: Edema (n= 17, 10%), skin thickening (n= 25, 15.9%), ser-
oma (n= 17, 10%), hematoma (n= 5, 3%), fat necrosis (n= 13, 7.6%), ﬁbrosis (n= 8, 4.7%),
and combined (n= 83, 48.8%). Residual malignancy found in 16.5% (n= 28) of cases.
No signiﬁcant difference was noted between DWI SI at b 850 versus 1000 and b 1000 versus 1500
(P> 0.05). Also no difference (P> 0.05) was noted between the mean ADC values of residual
malignant masses and post operative sequel of ﬁbrosis and fat necrosis. ADC map showed low
SI in 30% of cases. Statistical analysis yielded sensitivity, speciﬁcity and accuracy of 92.8%,
75.6% and 78% for contrast MRI and 92.8%, 82.6% and 83.4% for DWI respectively.
Conclusion: DWI enhanced the diagnostic performance of MRI in differentiating residual malig-
nancy from post operative changes.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
The importance of preventing local recurrence in women who
undergo breast-conserving therapy (BCT) for early-stage
breast cancer is underscored by the fact that local recurrence
is associated with increased cost, psychosocial distress for the
patient, and potentially worse distant disease-free and overall
survival (1).ed.
226 S.M. Mansour, N. BehairyFor many years DCE-MRI has been used for breast imag-
ing with variable applications starting from lesion character-
ization and staging of known carcinomas, passing by silicone
and non-silicone breast augmentation, screening of high-risk
patients and contralateral breast examination in patients with
breast malignancy, up to breast examination for postoperative
tissue reconstruction, detection of residual tumor or recurrence
of breast cancer (2).
The most important factor in the ability of MR imaging to
allow differentiation between neoplasia and posttreatment
changes is the integration of lesion morphology and enhance-
ment kinetics (3).
After breast conservative therapy, the incidence of ipsilat-
eral breast tumor recurrence (IBTR) is about 1% per year
for invasive breast cancer and is slightly less for ductal carci-
noma in situ (DCIS). Women who are at the greatest risk
for failure include those who are under 35 years old, women
with high-grade DCIS, women with DCIS measuring 2.5 cm
or greater in diameter, women treated for inﬁltrating ductal
carcinoma with a large DCIS component, and women with
multifocal disease (4).
Moreover, following TRAM ﬂap reconstruction, the uses
of MR imaging include (a) conﬁrming a benign imaging
impression as demonstrated at mammography and US, (b)
reinforcing radiologic suspicion of tumor recurrence as based
on conventional imaging modalities, or (c) documenting the
full extent of disease in cases of biopsy-proved recurrence (5).
Breast MRI is important in the postoperative work-up of
breast cancers. High sensitivity and speciﬁcity have been
reported for the diagnosis of recurrence; however, pitfalls such
as liponecrosis and changes after radiation therapy have to be
carefully considered. Dynamic contrast-enhanced MR and
Diffusion weighted-MRI have shown potential for improving
the early assessment of tumor response to therapy and the
assessment of residual tumor after the end of therapy (6).
The purpose of this work was to assess the ability of Diffu-
sion weighted MR imaging, being a non-invasive cost-effective
option compared to post contrast MRI, to solve the dilemma
of accepted post operative sequel vs residual malignancy dur-
ing follow up of breast cancer patients.
2. Patients and methods
2.1. Patients
The current work was a prospective analysis approved by the
Faculty of Medicine Ethics committee of the Cairo University;
cases were supplied by the Kasr ElAiny Hospital and have
given informed consent for their used data.
Diffusion-weighted MR scanning in addition to the routine
dynamic contrast-enhanced MRI protocol was done to 170
female patients.
The study cases were breast cancer patients that had been
candidates for; breast-conserving surgery (lumpectomy vs
quadrantectomy, n= 69), modiﬁed radical mastectomy
(n= 47) and reconstructive surgery (using silicone/saline
implants, n= 10 or autologous tissue reconstruction, n= 44).
MRI was requested to further assess operative bed residual
malignancy.
The majority of cases (n= 103) were scanned for MR at
our institute as a routine post operative follow up (6 monthsup to 2 years post surgery). The indication for MR imaging
in 67 cases (39.4%) was the presence of palpable abnormality
or pain at the site of the operative bed.
Findings were evaluated for analysis from March 2013 to
July 2014.2.2. Methods
High-resolution conventional ultrasound was performed for
all cases by 8–12 MHz linear array transducer (General Elec-
tric (GE), Logic 7 machine). Full ﬁeld digital mammography
was performed using GE Senograph 2000 Machine for 99
cases. Forty-seven cases with modiﬁed radical mastectomy
and another 24 cases with post operative inﬂammatory compli-
cations could not handle breast compression elicited during
mammography examination.2.2.1. Magnetic resonance imaging
Diffusion-weighted MR imaging was done to make use of its
capacity in discriminating benign post operative changes from
residual malignancy. Abnormalities scanned using the b val-
ues: zero, 850, 1000 and 1500 s/mm2.
MRI was performed for all cases using a 1.5-T magnet
(Gyroscan INTERA, Philips medical systems, Netherland).
Cases were imaged in the prone position using a dedicated
breast coil with eight channels.
The examination was ﬁrst performed by precontrast
sequences: Axial T1-weighted sequence spinecho (SE)-(TR/
TE 500/5.3 ms), sagittal and axial T2-weighted sequences SE
(TR/TE 120/4.9 ms) and axial T2-weighted inversion recovery
(IR)-(TR/TE 80/6.5 ms). For all the aforementioned sequences
slice thickness = 4 mm, matrix = 512 · 192, ﬂip angle = 90
and FVO= 34–37 cm.
We performed DW sequences for all the cases with the fol-
lowing parameters: TR/TE = 5000/77 ms; slice thick-
ness = 5 mm and 1 mm interslice gap; matrix = 124 · 100,
b-values (0, 850, 1000, 1500 s/mm2); and the diffusion image
was supplied from ‘‘Spectral Adiabatic Inversion Recovery’’
(SPAIR) MR sequence.
Sequentional post contrast MR examination was applied
for 166 cases; four cases had renal failure and consequently
contrast injection was contradicted.
Dynamic post contrast acquisition performed using six ser-
ies of 3D ‘‘T1 High Resolution Isotropic Volumetric Examina-
tion’’ THRIVE acquisition – 1 before & 5 after power injection
of 0.1 mmol/kg BW of contrast (Gd-DTPA) with the parame-
ters (TR/TE 2.8/9 ms) and slice thickness = 1.5 mm.2.3. Image analysis
MR image interpretation and quantitative analysis were per-
formed by qualiﬁed consultants of radiology, M.D. certiﬁed
(M.S. and B.N.) – 12 and 8 years experience in breast MR
imaging respectively.
The authors were blinded about the pathology results at the
time of initial evaluation. Also they were blinded about
each other’s MRI analysis. At the stage of ﬁnal evaluation,
there was multidisciplinary discussion of cases between the
radiology and breast surgeon consultants.
Diffusion-weighted imaging of post operative breasts 227In our interpretation, we looked for ﬁndings indicative of
cancer existence on DWI. Both qualitative and quantitative
data were considered.
Following (6) the qualitative analysis included;
(1) Visualization of abnormal bright signal intensity
(restricted diffusion) at/nearby the operative bed that
became enhanced with increasing b values
(850ﬁ 1000ﬁ 1500) at DW images.
(2) The ADC map presented intermediate/low signal inten-
sity (SI) that corresponded to the abnormality.
Regarding quantitative assessment; the ADC values were
measured manually by applying ROI on the post operative
breast abnormality. ROI was speciﬁcally placed at areas of
bright SI on DW images and intermediate/low SI on ADC
maps. For large masses; a large ROI applied to cover as much
as possible of the pathology, in case of masses with large cen-
tral liquefaction or cystic component; multiple ROIs were
applied to the abnormality marginal solid portion and theFig. 1 Female patient 43 years old, one year following right bre
10 months. (a) Axial T2 STIR showed right axillary ill-deﬁned solid m
operative bed. The pectoral muscle showed disrupted lateral ﬁbers an
showed high SI of the right axillary mass and no signal of the pectoral
high SI of the pectoral muscle. Persistent brightness at the high b value (
map conﬁrmed malignancy (i.e. post operative proliferated overlooked
DWI and its appreciation at the ADC map eliminated the possibility o
projection (MIP) 2 min post contrast injection axial image showed
involvement.mean ADC value was the value considered later in the data
calculation and analysis.
Following (7), we considered the cut off ADC value
between benign and malignant breast pathologies as
1.04 · 103 mm2/s.
The possible pathology suggested by MR imaging and
DWI of residual malignancy had been correlated with biopsy
(n= 22)/surgical pathology ﬁndings (n= 33) ± prior wire
localization in the latter situation. For suggested benign post
operative changes (n= 90), regressive course and/or complete
resolution of the condition was the standard reference.
We used software (SPSS for Windows, version 10.0.1, 1999;
SPSS, Chicago, IL) for statistical analysis.3. Results
Statistical analysis was performed for 170 post operative
breasts. The mean patient age was 39.3 ± 12.5 (range:
21–72) years.ast upper outer lumpectomy for invasive duct carcinoma since
asses with central liquefaction of the dominant one related to the
d edematous changes. (b) Axial DWI with b values (0 and1500)
muscle. (c) ADC map; the right axillary mass showed low SI and
1500) at DWI of the axillary mass together with low SI at the ADC
residual cancer) and disappearance of pectoral muscle bright SI at
f chest wall inﬁltration. (d) Three dimensional maximum intensify
axillary masses with feeding vessels and no pectoral muscle
Fig. 2 Female patient 45-year-old post right mastectomy with discovered mass at the ipsilateral axilla in follow up of an 18 month
period. (a) Axial T2 STIR showed a suspicious solid mass with a signet ring appearance at the right axilla. (b) Axial DWI with b values (0
and 1000) ADC map: the mass showed no restricted diffusion (no signal intensity) at the DWI and high SI in the ADC map. Findings
suggested benign diagnosis. True cut biopsy revealed operative bed ﬁbrofatty tissue showing an area of scarring and fat necrosis with a
foreign body giant cell reaction. (c) Axial 3D MIP showed no contrast uptake by the right axillary mass.
Table 1 Quantitative assessment of post operative breast on Diffusion-weighted imaging.
MRI ﬁndings of post operative changes
Edema Skin thickening Fluid collection (seroma) Hematoma Fat necrosis Fibrosis Combined ﬁndings
No. of cases = 170 (%) 17 (10) 27 (15.9) 17 (10) 5 (3) 13 (7.6) 8 (4.7) 83 (48.8)
DWI-Bright SI
b 850 17 (10) – 17 (10) 5 (3) 13 (7.6) 8 (4.7) 83
b 1000 – – 12 (7) 5 (3) 5 (3) 8 (4.7) 52 (30.5)
b 1500 – – – – – 5 (3) 31 (18.2)
ADC SI
Bright 17 (10) – 17 (10) 5 (3) 3 (1.7) – 50 (29.4)
Low – – – – 10 (5.8) 8 (4.7) 33 (19.4)
Note: Data are reported as numbers (percentages), SI = signal intensity; DWI = Diffusion-weighted imaging; ADC= apparent diffusion
coefﬁcient.
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Fig. 3 Fifty-six-year-old known case of breast cancer post left TRAM (transverse rectus abdominis myocutaneous) ﬂap breast
reconstruction since 12 months. (a) Axial T1-(right) and T2 STIR (left)-weighted images that showed tissue ﬂap replacement of the left
breast with a related upper outer macrolobulated heterogenous mass with bright components on T1WI that were suppressed in the T2
STIR sequence impressive of the fatty tissue. (b) Axial DWI at b 0 and 1000 and ADC map: the left TRAM-related mass showed no signal
at high b value and showed bright septae intervening low SI foci that correlated with the fatty tissue at the ADC map. (c) Axial post
contrast 3D MIP showed considerable early mottled enhancement of the left TRAM mass. Core tissue biopsy revealed fat necrosis. The
signal intensity at the pre-contrast sequences and the DWI was the one close to the actual diagnosis. Findings at both the ADC map and
post contrast study displayed misleading outcomes.
Table 2 Diagnostic performance of the post contrast MRI and DWI in the assessment of post operative breasts.
Examination TP TN FP FN Sensitivity (%) Speciﬁcity (%) Accuracy (%)
DCE-MRI 26 87 28 2 92.8 75.6 78
DWI 26 95 20 2 92.8 82.6 83.4
Note: Data are reported as numbers, DCE-MRI = dynamic contras enhanced MR imaging; DWI = Diffusion-weighted imaging; TP = true
positive; TN= true negative; FP = false positive; FN= false negative.
Diffusion-weighted imaging of post operative breasts 229The post operative changes were as follows: Edema
(n= 17, 10%), skin thickening (n= 25, 15.9%), ﬂuid collec-
tion (seroma) (n= 17, 10%) (Fig. 6), hematoma (n= 5,
3%), fat necrosis (n= 13, 7.6%) (Figs. 3 and 5), ﬁbrosis
(n= 8, 4.7%) (Fig. 4), and combined (n= 83, 48.8%) (Fig. 2).Malignant residual proliferation (Fig. 1) was found in
16.5% (n= 28) of the included cases.
Table 1 demonstrates the SI of the post operative
sequel/residual malignancy in DWI of the assessed
breasts.
Fig. 4 Female patient 40-years-old with left BCS since 12 months. (a) Right; axial T1 SE and left; axial T2 STIR sequences showed a left
upper inner suspicious ill-deﬁned lesion at the operative bed (arrow). Note, associate post operative changes of skin thickening and
interstitial edema. (b) Axial DWI at b 0 and 1000 and the ADC map: the left breast operative bed suspicious lesion showed facilitated
diffusion (circle) and a very low ADC value (0.4 · 103 mm2/s) characteristic of fatty tissue and suggested that the diagnosis was just
operative bed scar enclosing fat. (c) Kinetics: suspicious marginal enhancement (arrow) and early wash out curve pattern. (d) Axial post
contrast 3D MIP showed a small feeding vessel heading the operative bed (arrow). Pathology revealed scarring mammary tissue with no
evidence of residual in situ or invasive carcinoma. In the current case DWI ﬁndings were the ones compatible with the pathology.
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values: 850 versus 1000 (P> 0.05–0.6) and b 1000 versus
1500 (P 0.8).
Bright SI was displayed within the breast parenchyma in
DWI at b value 850 in 85.3% (n= 145) of the included breast
pathologies.
The abnormal brightness due to diffusion restriction
was persistent at b, 1000 in all the presented cases with
post operative hematoma and ﬁbrosis, 12 cases with ser-
oma, ﬁve cases with fat necrosis and in 52 cases out of
the 83 cases that showed combined features of operative
sequel.Further appreciation of restricted diffusion (bright SI) was
noted at b, 1500 in 36 cases (21.2%), most of them were resid-
ual malignancy (Fig. 1) (77.8%, n= 28/36).
In our analysis, we considered the persistence of bright SI
of the post operative abnormality in spite of increasing the b
value in the Diffusion-weighted sequence (i.e. 0, 850, 1000
and 1500) suggestive of malignant cells existence.
ADC map showed low signal intensity in 51 (30%, n=
51/170) cases; such SI was atypical in 23 (45%, n= 23/51)
cases with benign post operative sequel (10 cases fat necrosis,
8 cases ﬁbrosis and 5 cases with combined post operative
changes).
Fig. 5 Female patient 35-years-old with right BCS since 12 months. (a) Right; axial T2 STIR of the right breast showing operative bed
tiny bright focus at the operative bed (circle) and left; axial T2 STIR of the abdomen, showing multiple hepatic focal lesions likely
metastatic. Right breast operative bed focus was considered since there were hepatic focal masses and the focus itself had shown
enhancement in the dynamic post contrast study (c). (b) Axial DWI at b 0 and 1000 of the considered focus (circle) and ADC map with
ﬁndings excluding malignancy. (c) Right; axial post contrast 3D MIP and left; subtraction early post contrast that displayed focal
enhancement at the operative bed (arrow). (d) Time SI/curve data: relatively high SI% (70%) of the operative bed enhancing focus
(arrow). The surgical pathology specimen reported that the bed of previous excision showed areas of fat necrosis, reactive reparative
changes and ﬁbrocystic mastopathy. A single focus of atypical lobular hyperplasia was identiﬁed. No residual in situ or invasive
malignancy was noted.
Diffusion-weighted imaging of post operative breasts 231We measured the mean ADC values for the elicited post
operative abnormalities; so that we can overcome possible
overlap between the values of the benign and malignant condi-
tions. The mean ADC for benign sequel was 1.2 ± 0.34 ·
103 mm2/s, and for malignant tumors 0.83 ± 0.15 ·
103 mm2/s.
The mean ADC values of residual malignant masses and
some benign sequel as ﬁbrosis (0.77 ± 0.2 · 103 mm2/s) and
fat necrosis (0.56 ± 0.1 · 103 mm2/s) showed no signiﬁcant
difference (P> 0.05–0.333).
Dynamic post contrast sequence was not accessible in four
cases with renal failure; DWI with the aid of pre-contrast series
suggested the pathology to be fat necrosis in two cases, ﬁbrosis
in one case, and residual malignancy in one case.
In the post contrast MR study, breast abnormality
enhancement was noted in 98 cases (57.6%) where early
contrast uptake was noted in only 22 cases (Fig. 1) (13%).Malignant wash out curve pattern was noted in 6 cases out
of the proved 28 cases with residual malignancy.
Cases with post operative solo focal or diffuse skin thicken-
ing (n= 25) were considered for examination to check any
underlying abnormalities either with post contrast MR study
or the DW imaging. Both sequences showed no abnormalities
in such cases, so we had excluded them from our statistical
analysis.
No skin enhancement whether thickened or not was noted
in all the studied breasts.
Table 2 demonstrates the diagnostic performance of both
post contrast MR imaging and DWI in the assessment of
145 post operative breasts. Benign post operative changes pre-
sented by 117 cases and 28 cases had residual malignancy.
MRI evaluation of post operative breasts with the aid of
diffusion sequence and ADC values showed discordant out-
comes with the standard reference in 20 cases as false positive
Fig. 6 Female patient 65-years-old with right BCS since 6 months. (a) From right to left, axial T2 STIR, T2 FSE and T1 SE sequences
showed right upper outer complicated ﬂuid collection along the scar line with mural based loculi therein. Regarding the elicited SI, the
mass could be hematoma versus seroma with enclosed fat loculi. (b) Axial DWI at b 0 and 1000 and ADC map: here the diagnosis is more
likely to be seroma with enclosed fatty elements. (c) Axial 3D MIP showed faint marginal enhancement. Here DWI had excluded
malignancy and discriminated seroma from hematoma. Such ability could guide management of the post operative sequel as Un-resolving
postoperative hematomas cannot be aspirated (viscid blood), it should be evacuated under general anesthesia, while seroma could be easily
aspirated followed by antibiotic coverage.
232 S.M. Mansour, N. Behairy(Ten cases with fat necrosis, 5 with ﬁbrosis and 5 cases with
combined ﬁndings) and two cases as false negative (one case
was seroma with mural atypical cells and one case was edema
with no masses and biopsy revealed ductal carcinoma in situ
with microinvasion) diagnosis.
4. Discussion
DWI is an unenhanced MRI sequence which can provide
different and sometimes conﬁrmatory data to DCE-MRI
(8).
Presence of cancer cells in the vicinity of the primary tumor
after resection in a period between 3 and 12 months is more
likely a residual tumor. Most doctors consider a cancer to be
a recurrence if there were no signs of cancer for at least 2 years.
Others suggest local recurrence, to occur within 5 years of the
initial breast cancer diagnosis (9).
In the current study we evaluated the diagnostic perfor-
mance of DWI in the discrimination between post operative
changes and residual malignancy in the post operative follow
up studies starting from 6 months upwards and to see if there
was an added effect of its routine application to the established
MR examination of the breasts.
There was a paucity of references discussing the role of
MRI in evaluating post operative breasts, moreover DWI as
a special sequence.
According to Chen et al. (2012), the conspicuity of different
breast lesions on DWI will not be affected in spite of using var-
iable b values from 600 to 1000 s/mm2 at 1.5 T (10).
In the current work with the aid of variable b values (i.e.
850, 1000 and 1500), we was able to verify entities of post
operative changes (Figs. 2–6), in such a concept it is easy to
differentiate between simple/infected seroma, serous blood vsorganized hematoma and ﬁbrosis/scarring and fat necrosis vs
malignancy.
In 2010, Abdel Razek and co-authors (11) performed a
study to review the clinical applications of DWI of the breast;
they declared that DWI had a role in differentiating benign
breast entities from cancer. Although they stated that DWI
had the ability to differentiate between recurrent tumors from
posttreatment changes, the study had not analyzed the post
treatment follow up in depth.
According to us, DWI was not only able to exclude residual
malignancy (Figs. 2, 4 and 5), yet moreover it had helped in the
differentiation of various post operative changes (Figs. 3 and
6).
Partridge et al., found out that ADC measured low values
for malignancy than for benign breast lesions or normal tissue
(8), but during our work we observed comparable values
between malignancy and some post operative scar tissue (i.e.
ﬁbrosis) and fat necrosis.
In 2011, Woodhams and co-workers performed a review
article about the principles and the clinical application of Dif-
fusion weighted imaging in MRI breast examination. They
pointed out that the data provided by DWI, T2WI and the
ADC value could improve the speciﬁcity of breast MRI, more-
over the use of DWI on routine basis during breast MR exam-
ination could enhance the accuracy of such an examination
(12).
In the practical application of breast MR imaging; the ‘‘T1-
weighted SE’’ sequence is not used on a routine basis in most
of the institutes, yet from our experience the current sequence
is very important in the assessment of post operative breast; as
a part of post operative sequel may present by fat containing
lesions and tissue distortion seen at the operative bed (i.e. fat
necrosis and fat engulﬁng scar tissue) mimicking malignancy.
Diffusion-weighted imaging of post operative breasts 233Such conditions could be diagnosed by the presence of bright
fat SI within the lesion in T1WI that become suppressed in the
T2 STIR WI sequence (Figs. 3, 4 and 6) even in the presence of
misleading enhancement pattern and kinetics (Fig. 4).
Several studies have stated the mean ADC values for
benign and malignant lesions for DWI breast examination
on a performed 1.5 T MR device. Many references had consid-
ered the mean ADC values for different breast lesions evalua-
tion (11,13–17), regarding them as the range of the mean ADC
for malignant lesions was 0.85 ± 0.12 · 103 mm2/s up to
1.09 ± 0.27 · 103 mm2/s.
Previous studies (15,18–21) presented a cut off value of
ADC for diagnosing breast cancer that ranged from
1.13 · 103 mm2/s to 1.6 · 103 mm2/s.
Ei Khouli et al. (22), found out that DWI can improve the
characterization of breast lesions better than 3D T1-weigthed
and dynamic contrast-enhanced MR sequences provided con-
sidering ‘‘glandular tissue-normalized ADC values’’. They pro-
vided the following normalized ADC values: benign (mean
ADC, 1.1 ± 0.4 · 103 mm2/s, and malignant (mean ADC,
0.55 ± 0.16 · 103 mm2/s.
We presented mean ADC for benign sequel of 1.2 ± 0.34 ·
103 mm2/s, and for malignant tumors 0.83 ± 0.15 ·
103 mm2/s, but we used 1.5 T not 3.0 T MR device. Our
ADC values did not exceed the cut off values presented by
other research studies in discriminating post operative sequel
from residual malignancy.
In the current study, routine MR examination yielded a
sensitivity, speciﬁcity, and accuracy of 92.8%, 75.6% and
78% respectively.
When adding the data elicited by the DWI (including both
the SI pattern and the mean ADC values) to the MR assess-
ment, the statistical analysis presented 92.8% sensitivity,
82.6% speciﬁcity and 83.4% accuracy.
The limitation of the study involved the applied ROI as it
was placed at the ADC map on the areas of interest with base
selection on the T2WI SI, such an action had somehow
affected our data; as it may have resulted in an information
bias especially in the case of predominantly cystic masses with
thickened septae (seromas and hematomas). It would have
been better if the assessment performed on DW image was
merged with either the T2-weighted/post contrast images.
Unfortunately such software was not available on our MRI
device.
The strength of the current study lies in being a pioneer in
the special assessment of post operative breasts by DWI with a
good number and different varieties of included cases.
Moreover, DWI can be used as an alternative to contrast
sequences for patients with renal failure. Fortunately, conven-
tional MRI especially T1WI combined with DWI was able to
provide an accurate diagnoses in all of them.
5. Conclusion
DWI enhanced the diagnostic performance of MRI in the
detection of post operative residual malignancy in breast
cancer patients following surgical intervention.
Moreover, DWI together with pre-contrast MR sequences
can be a suitable alternative in case contrast media injection
was contraindicated.Conﬂict of interest
None.
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